Attorneys from The Phoenix Law Group joined Drug Topics at NCPDP 2025 to discuss the current state of pharmacy benefit manager reform and where it may end up in the near future.
A blood-based cell-free DNA (cfDNA) test was able to find patients at increased risk of colorectal cancer (CRC), advanced neoplasia, and advanced precancerous lesions.
Chronic pain is associated with a significant financial burden, with an estimated cost placed at $650 billion annually in the US.
For more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.
Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, discusses the impact of shifting guidance on vaccination strategies.
Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
Breast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.
The study could lead to early diagnosis and treatment of age-related macular degeneration.
A refresher on best interventions for common respiratory disorders in children.
When investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.
Is adherence packaging technology a big investment for a community or independent pharmacy?
OTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.
Clinical pharmacists transform diabetes care by leveraging manufacturer-sponsored patient assistance programs to dramatically improve medication access.
What are some key strategies for keeping your pharmacy thriving in 2025?
Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Findings from a systematic review found little difference in outcomes between biosimilar and reference product treatment options.
As more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children.
A deep dive for pharmacists into this frequently debilitating disorder
Experts discuss the evolving landscape of pharmacy through technological advancements, professional development, and advocacy.
Social media is a great way to gain exposure, but there are many dos-and-don’ts to understand when signing up for a social platform.
Patients with chronic lymphocytic leukemia experienced functional T cell and antibody responses after receiving a vaccine for COVID-19.
Recent meta-analysis takes a look at possible adverse effects of the acne medicine, their frequency and severity.
Lower costs, increased availability, and assistance programs are “game changers” for patients.
Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.
On September 28, the FDA granted approval to oral atogepant (Qulipta) for the prevention of migraine.
In this episode of the podcast, Natalie DiPietro Mager, PharmD, PhD, sits down with Jasmine Cutler, PharmD, CPh.
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses the importance of insulin delivery and the common barriers pharmacists face in managing patients’ regimens.
This new drug utilizes the bactericidal properties of taurolidine and the bloodthinning effects of heparin to maintain catheter patency.